Published in Infect Immun on August 01, 2001
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A (2003) 4.56
Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog (2008) 4.05
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A (2005) 3.30
Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog (2009) 2.69
Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun (2004) 2.53
T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe (2011) 2.30
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun (2006) 2.20
Pneumonia research to reduce childhood mortality in the developing world. J Clin Invest (2008) 2.01
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun (2005) 1.86
Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun (2007) 1.83
Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun (2007) 1.45
Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun (2008) 1.39
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine (2010) 1.37
Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model. Infect Immun (2009) 1.35
Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun (2005) 1.35
Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine. Clin Vaccine Immunol (2010) 1.25
Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant. Infect Immun (2004) 1.18
Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog (2012) 1.18
Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol (2009) 1.18
Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog (2011) 1.14
Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide. Infect Immun (2009) 1.13
Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. J Infect Dis (2010) 1.11
Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc Natl Acad Sci U S A (2012) 1.09
PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae. Infect Immun (2009) 1.09
Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine (2012) 1.07
Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev (2008) 1.07
The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun (2010) 1.05
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis. Vaccine (2010) 1.03
Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase. Proc Natl Acad Sci U S A (2012) 0.99
Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease. Infect Immun (2006) 0.98
The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. Vaccine (2009) 0.97
Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae. Infect Immun (2010) 0.93
Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization. Infect Immun (2010) 0.92
Impaired innate mucosal immunity in aged mice permits prolonged Streptococcus pneumoniae colonization. Infect Immun (2013) 0.89
The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens. PLoS One (2012) 0.88
Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine. PLoS One (2012) 0.87
Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium. J Ind Microbiol Biotechnol (2008) 0.85
Effect of Serotype on Pneumococcal Competition in a Mouse Colonization Model. MBio (2015) 0.84
Mouse models for the study of mucosal vaccination against otitis media. Vaccine (2008) 0.83
Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide. Microb Pathog (2009) 0.82
Respiratory microbiota dynamics following Streptococcus pneumoniae acquisition in young and elderly mice. Infect Immun (2014) 0.81
A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi. Vaccine (2012) 0.81
Mechanisms and impact of genetic recombination in the evolution of Streptococcus pneumoniae. Comput Struct Biotechnol J (2015) 0.80
Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response. J Immune Based Ther Vaccines (2011) 0.80
Application of radiation technology in vaccines development. Clin Exp Vaccine Res (2015) 0.78
Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins. Infect Immun (2014) 0.78
Dried Saliva Spots: A Robust Method for Detecting Streptococcus pneumoniae Carriage by PCR. Int J Mol Sci (2016) 0.78
Effect of nonheme iron-containing ferritin Dpr in the stress response and virulence of pneumococci. Infect Immun (2014) 0.77
T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins. Clin Vaccine Immunol (2015) 0.76
From Immunologically Archaic to Neoteric Glycovaccines. Vaccines (Basel) (2017) 0.75
Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice. Clin Exp Vaccine Res (2013) 0.75
Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins. Clin Vaccine Immunol (2014) 0.75
Otitis-prone children produce functional antibodies to pneumolysin and pneumococcal polysaccharides. Clin Vaccine Immunol (2016) 0.75
A combination of recombinant BCG expressing pneumococcal proteins induces cellular and humoral immune responses and protects against pneumococcal colonization and sepsis. Clin Vaccine Immunol (2017) 0.75
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J (2000) 11.94
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med (1981) 6.45
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation. Mol Gen Genet (1974) 4.93
Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect Immun (1989) 3.45
The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun (1999) 2.94
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun (2001) 2.68
Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun (2000) 2.64
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis (2000) 2.55
Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis (1999) 2.55
ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI. J Exp Med (1928) 2.44
Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog (1997) 2.41
PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine (1996) 2.08
Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Microb Pathog (1996) 1.91
Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. JAMA (1992) 1.86
Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis (1996) 1.52
A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect Immun (1998) 1.33
Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection. Infect Immun (1999) 1.18
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine (2000) 1.07
WHO meeting on maternal and neonatal pneumococcal immunization. Wkly Epidemiol Rec (1998) 1.07
Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine. Infect Immun (2001) 1.02
Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats. Infect Immun (1997) 0.97
Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant. J Infect Dis (2000) 0.96
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant. Dev Biol Stand (1998) 0.88
A simple and rapid method for the preparation of plant genomic DNA for PCR analysis. Nucleic Acids Res (1991) 11.96
How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci (2007) 8.51
RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol (1999) 8.07
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med (1996) 6.92
Engineering herbicide resistance in plants by expression of a detoxifying enzyme. EMBO J (1987) 6.77
Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans (2002) 6.08
Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol (2000) 5.99
mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev (1993) 5.94
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc Natl Acad Sci U S A (1986) 5.47
Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. Proc Natl Acad Sci U S A (1981) 4.85
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med (1999) 4.66
Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci U S A (1999) 4.62
TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J (2000) 4.41
Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet (2011) 4.35
Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol (1997) 4.28
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut (2009) 4.06
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet (2001) 3.96
Novel form of growth cone motility involving site-directed actin filament assembly. Nature (1992) 3.73
Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol (2013) 3.72
A new kind of informational suppression in the nematode Caenorhabditis elegans. Genetics (1989) 3.69
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA (1997) 3.68
The unhealthy lifestyle of people with schizophrenia. Psychol Med (1999) 3.54
Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ (1999) 3.52
The population genetics of antibiotic resistance. Clin Infect Dis (1997) 3.51
Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci U S A (1997) 3.48
Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science (1999) 3.40
Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33
Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun (2001) 3.28
SMG-2 is a phosphorylated protein required for mRNA surveillance in Caenorhabditis elegans and related to Upf1p of yeast. Mol Cell Biol (1999) 3.18
General practitioners and alternative medicine. J R Coll Gen Pract (1987) 3.10
Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect (1999) 3.07
Life and death in the cytoplasm: messages from the 3' end. Curr Opin Genet Dev (1997) 3.01
Activation of a transposable element in the germ line but not the soma of Caenorhabditis elegans. Nature (1987) 3.00
The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol Cell (2000) 2.97
Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities. J Biol Chem (1996) 2.89
Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules. J Cell Biol (1971) 2.88
Natural selection, infectious transfer and the existence conditions for bacterial plasmids. Genetics (2000) 2.84
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast. Proc Natl Acad Sci U S A (1997) 2.78
Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer (1989) 2.68
Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood (1996) 2.62
Intergeneric conjugation between Escherichia coli and Streptomyces species. J Bacteriol (1989) 2.62
Regeneration of a functional RNA virus genome by recombination between deletion mutants and requirement for cowpea chlorotic mottle virus 3a and coat genes for systemic infection. Proc Natl Acad Sci U S A (1990) 2.61
Increased rate of tuberculin skin test conversion among workers at a university hospital. Infect Control Hosp Epidemiol (1992) 2.60
Inhibition of protein synthesis by spectinomycin. Science (1965) 2.54
What are safe levels of alcohol consumption? Br Med J (Clin Res Ed) (1984) 2.54
Unproductively spliced ribosomal protein mRNAs are natural targets of mRNA surveillance in C. elegans. Genes Dev (2000) 2.52
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A (1992) 2.38
Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis (1986) 2.34
Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33
Transposition of Tc1 in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1985) 2.33
Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun (1991) 2.22
Bacterial SOS checkpoint protein SulA inhibits polymerization of purified FtsZ cell division protein. J Bacteriol (1998) 2.15
The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc Natl Acad Sci U S A (1995) 2.15
Development of executive functions through late childhood and adolescence in an Australian sample. Dev Neuropsychol (2001) 2.14
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A (2000) 2.13
A selection for myosin heavy chain mutants in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1984) 2.10
A method to compare costs of drugs and supplies among anesthesia providers: a simple statistical method to reduce variations in cost due to variations in casemix. Anesthesiology (1998) 2.08
Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet (1995) 2.08
Safe limits of drinking: general practitioners' views. Br Med J (Clin Res Ed) (1985) 2.06
Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol (2000) 2.05
Supercoiling in closed circular DNA: dependence upon ion type and concentration. Biochemistry (1978) 2.01
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Umbilical cords: turning garbage into clinical gold. Science (1995) 2.01
Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infect Immun (1983) 1.99
Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication. J Virol (2002) 1.98
Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr (1997) 1.98
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 1.95
Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am J Pathol (1993) 1.94
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Community general practitioner. Lancet (1985) 1.94
Effect of spectinomycin on polypeptide synthesis in extracts of Escherichia coli. J Mol Biol (1967) 1.93
The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int (2003) 1.93
Site-selected insertion of the transposon Tc1 into a Caenorhabditis elegans myosin light chain gene. Mol Cell Biol (1993) 1.92
The effects of explicit timing on math performance. J Appl Behav Anal (1976) 1.91
smg-7 is required for mRNA surveillance in Caenorhabditis elegans. Genetics (1999) 1.90
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
G proteins are required for spatial orientation of early cell cleavages in C. elegans embryos. Cell (1996) 1.86
Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ (2011) 1.85
The AAPPQ revisited: the measurement of general practitioners' attitudes to alcohol problems. Br J Addict (1987) 1.85
Evaluation of the LMA Supreme in 100 non-paralysed patients. Anaesthesia (2009) 1.85
Insertion and excision of Caenorhabditis elegans transposable element Tc1. Mol Cell Biol (1988) 1.80
The gene structures of spontaneous mutations affecting a Caenorhabditis elegans myosin heavy chain gene. Genetics (1985) 1.79
Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B. J Immunol (1978) 1.79
Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill (2011) 1.76
RNA-binding protein TIAR is essential for primordial germ cell development. Proc Natl Acad Sci U S A (1998) 1.76
Death, autoantigen modifications, and tolerance. Arthritis Res (2000) 1.75
Anogenital warts in childhood. Child Abuse Negl (1989) 1.75
Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. Leuk Lymphoma (2005) 1.75
Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med (1995) 1.75
Diabetes and extreme altitude mountaineering. Br J Sports Med (2001) 1.75
Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron (1993) 1.74
Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax (2009) 1.74
Advances in the molecular genetic analysis of the flax-flax rust interaction. Annu Rev Phytopathol (1997) 1.72